Operative Therapie kolorektaler Lebermetastasen – Multimodale Zentrumschirurgie

Die operative Entfernung von kolorektalen Lebermetastasen ist der einzige kurative Therapieansatz für diese Erkrankung. Das Vorgehen hängt dabei von der Ausprägung der Lebermetastasierung und der Konstitution des Patienten ab. Oft kommen multimodale Therapiekonzepte zur Anwendung, die eine hohe Expertise erfordern – somit ist in jedem Fall eine interdisziplinäre Konsensentscheidung zur Festlegung der optimalen Therapiestrategie notwendig.

Schlüsselwörter

Lebermetastasen - kolorektales Karzinom - Leberchirurgie - multimodale Therapie

• Literatur

• 1 Robert Koch-Institut (RKI). Krebs in Deutschland für 2019/2020. 14. Ausgabe. Gemeinsame Publikation des Zentrums für Krebsregisterdaten und der Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V.. Berlin: RKI; 2023
• 2 Torzilli G, Adam R, Vigano L. et al. Surgery of colorectal liver metastases: Pushing the limits. Liver Cancer 2016; 6: 80-89
• 3 Couinaud C. [Liver lobes and segments: notes on the anatomical architecture and surgery of the liver]. Presse Med (1893) 1954; 62: 709-712
• 4 Topp S, Aissa J, Quentin M. et al. Einteilung der Resektionsverfahren. In: Schultheis K, Mödder U, Antoch G. et al. , Hrsg. Chirurgie und Bildgebung. Stuttgart: Thieme; 2018.
• 5 Huiskens J, Bolhuis K, Engelbrecht MR. et al. Outcomes of resectability assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel. J Am Coll Surg 2019; 229: 523-532.e2
• 6 Torzilli G, McCormack L, Pawlik T. Parenchyma-sparing liver resections. Int J Surg 2020; 82S: 192-197
• 7 Deng G, Li H, Jia GQ. et al. Parenchymal-sparing versus extended hepatectomy for colorectal liver metastases: A systematic review and meta-analysis. Cancer Med 2019; 8: 6165-6175
• 8 Stockmann M, Lock JF, Malinowski M. et al. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB (Oxford) 2010; 12: 139-146
• 9 Thomas MN, Weninger E, Angele M. et al. Intraoperative simulation of remnant liver function during anatomic liver resection with indocyanine green clearance (LiMON) measurements. HPB (Oxford) 2015; 17: 471-476
• 10 Nordlinger B, Van Cutsem E, Rougier P. et al. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer 2007; 43: 2037-2045
• 11 Nordlinger B, Guiguet M, Vaillant JC. et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996; 77: 1254-1262
• 12 Fong Y, Fortner J, Sun RL. et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318 discussion 318–321
• 13 Adam R, de Haas RJ, Wicherts DA. et al. Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery?. Ann Surg 2011; 253: 349-359
• 14 Hellingman T, de Swart ME, Heymans MW. et al. Repeat hepatectomy justified in patients with early recurrence of colorectal cancer liver metastases: A systematic review and meta-analysis. Cancer Epidemiol 2021; 74: 101977
• 15 Sadot E, Groot Koerkamp B, Leal JN. et al. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?. Ann Surg 2015; 262: 476-485
• 16 Symeonidis D, Tepetes K, Tzovaras G. et al. Colorectal cancer liver metastases: Is an R1 hepatic resection accepted?. Clin Pract 2022; 12: 1102-1110
• 17 Yilmaz E, Torsello GF, Hosseini ASA. et al. Role of liver augmentation prior to hepatic resection – a survey on standards, procedures, and indications in Germany, Switzerland, and Austria. Langenbecks Arch Surg 2024; 409: 228
• 18 Moris D, Ronnekleiv-Kelly S, Kostakis ID. et al. Operative results and oncologic outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) versus Two-Stage Hepatectomy (TSH) in patients with unresectable colorectal liver metastases: a systematic review and meta-analysis. World J Surg 2018; 42: 806-815
• 19 Memeo R, Conticchio M, Deshayes E. et al. Optimization of the future remnant liver: review of the current strategies in Europe. Hepatobiliary Surg Nutr 2021; 10: 350-363
• 20 Lam VW, Laurence JM, Johnston E. et al. A systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases. HPB (Oxford) 2013; 15: 483-491
• 21 Lang H, Baumgart J, Mittler J. Associated Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Registry: What have we learned?. Gut Liver 2020; 14: 699-706
• 22 Linecker M, Kambakamba P, Reiner CS. et al. How much liver needs to be transected in ALPPS? A translational study investigating the concept of less invasiveness. Surgery 2017; 161: 453-464
• 23 Schadde E, Raptis DA, Schnitzbauer AA. et al. Prediction of mortality after ALPPS Stage-1: An analysis of 320 patients from the International ALPPS Registry. Ann Surg 2015; 262: 780-785 discussion 785–786
• 24 Hernandez-Alejandro R, Ruffolo LI, Alikhanov R. et al. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) procedure for colorectal liver metastasis. Int J Surg 2020; 82S: 103-108
• 25 Oldhafer KJ, Stavrou GA, van Gulik TM. et al. ALPPS – Where do we stand, where do we go?: Eight recommendations from the First International Expert Meeting. Ann Surg 2016; 263: 839-841
• 26 Wei D, Johnston S, Patkar A. et al. Comparison of clinical and economic outcomes between minimally invasive liver resection and open liver resection: a propensity-score matched analysis. HPB (Oxford) 2021; 23: 785-794
• 27 Morise Z, Aldrighetti L, Belli G. et al. Laparoscopic repeat liver resection for hepatocellular carcinoma: a multicentre propensity score-based study. Br J Surg 2020; 107: 889-895
• 28 Chan G, Chee CE. Perioperative chemotherapy for liver metastasis of colorectal cancer. Cancers (Basel) 2020; 12: 3535
• 29 Guo M, Jin N, Pawlik T. et al. Neoadjuvant chemotherapy for colorectal liver metastases: A contemporary review of the literature. World J Gastrointest Oncol 2021; 13: 1043-1061
• 30 Bolhuis K, Kos M, van Oijen MGH. et al. Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review. Eur J Cancer 2020; 141: 225-238
• 31 Chua TC, Saxena A, Liauw W. et al. Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol 2010; 17: 492-501
• 32 Nigri G, Petrucciani N, Ferla F. et al. Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies. Surgeon 2015; 13: 83-90
• 33 Nordlinger B, Sorbye H, Glimelius B. et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 2013; 14: 1208-1215
• 34 Georgilis E, Gavriatopoulou M, Tsilimigras DI. et al. Optimizing adjuvant therapy after surgery for colorectal cancer liver metastases: a systematic review. J Clin Med 2023; 12: 2401
• 35 Van Cutsem E, Cervantes A, Adam R. et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 2016; 27: 1386-1422
• 36 Fan CQ, Crawford JM. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol 2014; 4: 332-346
• 37 Muhlbacher F, Huk I, Steininger R. et al. Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver?. Transplant Proc 1991; 23: 1567-1568
• 38 Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991; 110: 726-734 discussion 734–735
• 39 Hagness M, Foss A, Line PD. et al. Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg 2013; 257: 800-806
• 40 Smedman TM, Line PD, Hagness M. et al. Liver transplantation for unresectable colorectal liver metastases in patients and donors with extended criteria (SECA-II arm D study). BJS Open 2020; 4: 467-477
• 41 Puia-Negulescu S, Lebosse F, Mabrut JY. et al. Liver transplantation for colorectal liver metastases: current management and future perspectives. Int J Mol Sci 2021; 22: 3093
• 42 Adam R, Piedvache C, Chiche L. et al. Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial. Lancet 2024; 404: 1107-1118
• 43 Ishii M, Mizuguchi T, Harada K. et al. Comprehensive review of post-liver resection surgical complications and a new universal classification and grading system. World J Hepatol 2014; 6: 745-751
• 44 Ocak I, Topaloglu S, Acarli K. Posthepatectomy liver failure. Turk J Med Sci 2020; 50: 1491-1503
• 45 Paugam-Burtz C, Janny S, Delefosse D. et al. Prospective validation of the “fifty-fifty” criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg 2009; 249: 124-128
• 46 Jin S, Fu Q, Wuyun G. et al. Management of post-hepatectomy complications. World J Gastroenterol 2013; 19: 7983-7991
• 47 Vlaemynck K, Lahousse L, Vanlander A. et al. Endoscopic management of biliary leaks: a systematic review with meta-analysis. Endoscopy 2019; 51: 1074-1081